The JUPITER registry: One ‐year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation

ConclusionsThe JenaValve overcomes technical challenges of TAVR in AR through a clipping mechanism. We report satisfactory outcomes of a multicenter registry using the JenaValve for predominant AR, as rate of THV embolization, residual AR and permanent pacemaker implantation was low. One‐year results using the JenaValve for AR encourage its use for this indication.

Source: Catheterization and Cardiovascular Interventions - November 24, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Miriam Silaschi, Lenard Conradi, Olaf Wendler, Friederike Schlingloff, Utz Kappert, Ardawan J Rastan, Hardy Baumbach, David Holzhey, Walter Eichinger, Ralf Bader, Hendrik Treede Tags: Valvular and Structural Heart Diseases Source Type: research